{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:21:59Z","timestamp":1767651719956},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.antiviral.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T20:18:23Z","timestamp":1437250703000},"page":"138-144","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice"],"prefix":"10.1016","volume":"121","author":[{"given":"Adelina","family":"Stoyanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivanka","family":"Nikolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel S.","family":"Galabov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.07.004_b0005","first-page":"1523","article-title":"Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis","volume":"36","author":"Abzug","year":"2003","journal-title":"Pediatr. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.004_b0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00006454-200104000-00022","article-title":"Severe neonatal enteroviral hepatitis treated with pleconaril","volume":"20","author":"Aradottir","year":"2001","journal-title":"Pediatr. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.004_b0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/1348-0421.12261","article-title":"Phosphatidylinositol 4-kinase III beta is the target of oxoglaucine and pachydipol (Ro 09\u20130179) for anti-picornavirus activity","volume":"59","author":"Arita","year":"2015","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.07.004_b0020","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2174\/138161206776361129","article-title":"Current status of anti-picornavirus therapies","volume":"12","author":"Barnard","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2015.07.004_b0025","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.71.11.8482-8489.1997","article-title":"Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C","volume":"71","author":"Barton","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.07.004_b0030","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrmicro1769","article-title":"Vaccination against polio should not be stopped","volume":"5","author":"Chumakov","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2015.07.004_b0035","unstructured":"Clinical Trials.gov.US. National Institute s of Health, 2007. Effect of pleconaril nasal spray on common cold symptoms and asthma exacerbation following rhinovirus exposure (Study P04295AM2). <http:\/\/.clinicaltrials.gov\/ct\/gui\/show\/NCT00394914> (retrieved 2007.04.10)."},{"key":"10.1016\/j.antiviral.2015.07.004_b0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.20125","article-title":"Selective inhibitors of picornavirus replication","volume":"28","author":"De Palma","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2015.07.004_b0045","first-page":"3","article-title":"Coxsackieviruses and quasispecies theory: evolution of enteroviruses","volume":"323","author":"Domingo","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.07.004_b0050","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1073\/pnas.38.8.747","article-title":"Production of plaques in monolayer tissue cultures by single particles of an animal virus","volume":"32","author":"Dulbecco","year":"1952","journal-title":"Proc. Natl. Acad. Sci. Wash."},{"key":"10.1016\/j.antiviral.2015.07.004_b0055","series-title":"RNA Genetics","first-page":"211","article-title":"Sequence space and quasispecies distribution","volume":"vol. 3","author":"Eigen","year":"1988"},{"key":"10.1016\/j.antiviral.2015.07.004_b0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/187152106777697826","article-title":"Antiviral agents in the prevention and treatment of virus-induced diabetes","volume":"5","author":"Galabov","year":"2006","journal-title":"AntiInfect. Agents Med. Chem."},{"key":"10.1016\/j.antiviral.2015.07.004_b0065","series-title":"New Trends of Microbiology (65th Anniversary of the Stephan Angeloff Institute of Microbiology, The Stephan Angeloff Institute of Microbiology","first-page":"47","article-title":"Perspectives for effective chemotherapy of enterovirus infections","author":"Galabov","year":"2012"},{"key":"10.1016\/j.antiviral.2015.07.004_b0070","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/314758","article-title":"Attenuated virulence of pleconaril-resistant Coxsackievirus B3 variants","volume":"179","author":"Groarke","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.004_b0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/AAC.39.2.290","article-title":"Intranasal pirodavir (R77,975) treatment of rhinovirus colds","volume":"39","author":"Hayden","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.07.004_b0080","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/375069","article-title":"Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials","volume":"36","author":"Hayden","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.004_b0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3181\/00379727-107-26560","article-title":"Plaque-inhibition tests for detection of specific inhibitors of DNA containing viruses","volume":"107","author":"Herrmann","year":"1961","journal-title":"Proc. Soc. Exp. Biol."},{"key":"10.1016\/j.antiviral.2015.07.004_b0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0166-3542(82)90003-1","article-title":"Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles","volume":"2","author":"Herrmann","year":"1982","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.07.004_b0095","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00125-002-0852-3","article-title":"The role of viruses in human diabetes","volume":"45","author":"Hy\u00f6ty","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.antiviral.2015.07.004_b0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/diab.44.6.652","article-title":"A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group","volume":"44","author":"Hy\u00f6ty","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.antiviral.2015.07.004_b0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0163-7258(80)90026-1","article-title":"Development of drug resistance and dependence in viruses","volume":"10","author":"Loddo","year":"1980","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.antiviral.2015.07.004_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/193097a0","article-title":"In vitro inhibition of infectivity of polio viruses by guanidine","volume":"193","author":"Loddo","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.07.004_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/138161207779313777","article-title":"Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations","volume":"13","author":"Mallia","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2015.07.004_b0120","doi-asserted-by":"crossref","DOI":"10.1126\/science.134.3478.557","article-title":"Rapid development of drug-resistant mutants of poliovirus","volume":"134","author":"Melnick","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.07.004_b0125","series-title":"Human Enterovirus Infections","first-page":"3","article-title":"Epidemiology","author":"Morens","year":"1995"},{"key":"10.1016\/j.antiviral.2015.07.004_b0130","first-page":"199","article-title":"A new highly potent antienteroviral compound","volume":"vol. I","author":"Nikolaeva-Glomb","year":"2008"},{"key":"10.1016\/j.antiviral.2015.07.004_b0135","series-title":"Fields Virology","first-page":"895","article-title":"Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses","author":"Pallansch","year":"2006"},{"key":"10.1016\/j.antiviral.2015.07.004_b0140","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.07.004_b0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/318452","article-title":"Treatment of potentially life-threatening enterovirus infections with pleconaril","volume":"32","author":"Rotbart","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.004_b0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/315176","article-title":"Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection","volume":"181","author":"Schiff","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.004_b0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(02)00277-3","article-title":"FDA panel rejects common cold treatment","volume":"2","author":"Senior","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.07.004_b0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AEM.9.1.66-72.1961","article-title":"A plaque suppression method for the study of antiviral compounds","volume":"9","author":"Siminoff","year":"1961","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2015.07.004_b0165","series-title":"Viruses and Human Disease","first-page":"63","article-title":"Plus-Strand RNA Viruses","author":"Strauss","year":"2008"},{"key":"10.1016\/j.antiviral.2015.07.004_b0170","first-page":"21","article-title":"Viruses in asthma exacerbations","volume":"11","author":"Tan","year":"2005","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.antiviral.2015.07.004_b0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jac\/dki329","article-title":"Virucidal hand treatments for prevention of rhinovirus infection","volume":"56","author":"Turner","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2015.07.004_b0180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.antiviral.2009.11.003","article-title":"Avoiding drug-resistance development by novel approach of combining enteroviral substances against coxsackievirus B1 infection in mice","volume":"85","author":"Vassileva-Pencheva","year":"2010","journal-title":"Antiviral Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T02:16:03Z","timestamp":1599272163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":36,"alternative-id":["S0166354215001679"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.07.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}